Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment
Authors
Keywords
Fc gamma receptor (FcgR), Oncolytic virus, NK cell, GM-CSF, CD40L
Journal
Journal of Translational Medicine
Volume 11, Issue 1, Pages 193
Publisher
Springer Nature
Online
2013-08-21
DOI
10.1186/1479-5876-11-193
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
- (2013) A. Kanerva et al. CLINICAL CANCER RESEARCH
- Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
- (2013) Ilkka Liikanen et al. MOLECULAR THERAPY
- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- Analysis of Fc Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer Patients
- (2012) S. A. Hurvitz et al. CLINICAL CANCER RESEARCH
- Verapamil Results in Increased Blood Levels of Oncolytic Adenovirus in Treatment of Patients With Advanced Cancer
- (2011) Anniina Koski et al. MOLECULAR THERAPY
- Fragment c gamma receptor gene polymorphisms and breast cancer risk in case–control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians
- (2010) Motoki Iwasaki et al. BREAST CANCER RESEARCH AND TREATMENT
- Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients
- (2010) Vincenzo Cerullo et al. CANCER RESEARCH
- Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer
- (2010) Jan Pander et al. EUROPEAN JOURNAL OF CANCER
- Human platelet FcγRIIA and phagocytes in immune-complex clearance
- (2010) Zhen-Yu Huang et al. MOLECULAR IMMUNOLOGY
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
- (2010) Anniina Koski et al. MOLECULAR THERAPY
- Functional and clinical consequences of Fc receptor polymorphic and copy number variants
- (2009) S. Bournazos et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Oncolytic viruses from the perspective of the immune system
- (2009) Ramon Alemany et al. Future Microbiology
- Fcγ receptors: structure, function and role as genetic risk factors in SLE
- (2009) X Li et al. GENES AND IMMUNITY
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- Current Issues and Future Directions of Oncolytic Adenoviruses
- (2009) Masato Yamamoto et al. MOLECULAR THERAPY
- Fc receptor-mediated antiviral antibodies
- (2009) Donald N Forthal et al. Current Opinion in HIV and AIDS
- Oncolytic viruses: a novel form of immunotherapy
- (2008) Robin J Prestwich et al. Expert Review of Anticancer Therapy
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now